Jumping to conclusions, general intelligence, and psychosis liability: findings from the multi-centre EU-GEI case-control study.
First episode psychosis
IQ
jumping to conclusions
polygenic risk score
psychotic-like experiences
symptom dimensions
Journal
Psychological medicine
ISSN: 1469-8978
Titre abrégé: Psychol Med
Pays: England
ID NLM: 1254142
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
pubmed:
25
4
2020
medline:
16
11
2021
entrez:
25
4
2020
Statut:
ppublish
Résumé
The 'jumping to conclusions' (JTC) bias is associated with both psychosis and general cognition but their relationship is unclear. In this study, we set out to clarify the relationship between the JTC bias, IQ, psychosis and polygenic liability to schizophrenia and IQ. A total of 817 first episode psychosis patients and 1294 population-based controls completed assessments of general intelligence (IQ), and JTC, and provided blood or saliva samples from which we extracted DNA and computed polygenic risk scores for IQ and schizophrenia. The estimated proportion of the total effect of case/control differences on JTC mediated by IQ was 79%. Schizophrenia polygenic risk score was non-significantly associated with a higher number of beads drawn (B = 0.47, 95% CI -0.21 to 1.16, p = 0.17); whereas IQ PRS (B = 0.51, 95% CI 0.25-0.76, p < 0.001) significantly predicted the number of beads drawn, and was thus associated with reduced JTC bias. The JTC was more strongly associated with the higher level of psychotic-like experiences (PLEs) in controls, including after controlling for IQ (B = -1.7, 95% CI -2.8 to -0.5, p = 0.006), but did not relate to delusions in patients. Our findings suggest that the JTC reasoning bias in psychosis might not be a specific cognitive deficit but rather a manifestation or consequence, of general cognitive impairment. Whereas, in the general population, the JTC bias is related to PLEs, independent of IQ. The work has the potential to inform interventions targeting cognitive biases in early psychosis.
Sections du résumé
BACKGROUND
The 'jumping to conclusions' (JTC) bias is associated with both psychosis and general cognition but their relationship is unclear. In this study, we set out to clarify the relationship between the JTC bias, IQ, psychosis and polygenic liability to schizophrenia and IQ.
METHODS
A total of 817 first episode psychosis patients and 1294 population-based controls completed assessments of general intelligence (IQ), and JTC, and provided blood or saliva samples from which we extracted DNA and computed polygenic risk scores for IQ and schizophrenia.
RESULTS
The estimated proportion of the total effect of case/control differences on JTC mediated by IQ was 79%. Schizophrenia polygenic risk score was non-significantly associated with a higher number of beads drawn (B = 0.47, 95% CI -0.21 to 1.16, p = 0.17); whereas IQ PRS (B = 0.51, 95% CI 0.25-0.76, p < 0.001) significantly predicted the number of beads drawn, and was thus associated with reduced JTC bias. The JTC was more strongly associated with the higher level of psychotic-like experiences (PLEs) in controls, including after controlling for IQ (B = -1.7, 95% CI -2.8 to -0.5, p = 0.006), but did not relate to delusions in patients.
CONCLUSIONS
Our findings suggest that the JTC reasoning bias in psychosis might not be a specific cognitive deficit but rather a manifestation or consequence, of general cognitive impairment. Whereas, in the general population, the JTC bias is related to PLEs, independent of IQ. The work has the potential to inform interventions targeting cognitive biases in early psychosis.
Identifiants
pubmed: 32327005
doi: 10.1017/S003329171900357X
pii: S003329171900357X
pmc: PMC8020493
doi:
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
623-633Subventions
Organisme : Medical Research Council
ID : MR/L010305/1
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 101272/Z/12/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/T007818/1
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Références
Int J Mol Sci. 2018 Nov 30;19(12):
pubmed: 30513630
Br J Psychiatry. 2013 Nov;203(5):327-33
pubmed: 24187067
Schizophr Bull. 2015 Sep;41(5):1183-91
pubmed: 25616503
Comput Psychiatr. 2019 Feb;3:18-39
pubmed: 30931393
Mol Psychiatry. 2019 Mar;24(3):409-420
pubmed: 29317742
Brain. 2019 Jun 1;142(6):1797-1812
pubmed: 30895299
Eur Psychiatry. 2014 Jun;29(5):275-81
pubmed: 24176646
Psychol Med. 2019 Oct;49(13):2256-2266
pubmed: 30392491
Psychiatry Res. 2009 Dec 30;170(2-3):119-23
pubmed: 19906438
Schizophr Res. 2018 May;195:366-371
pubmed: 28969933
Psychiatry Res. 2014 Aug 30;218(3):341-7
pubmed: 24836199
Schizophr Res. 2013 Dec;151(1-3):61-9
pubmed: 24183707
Q J Exp Psychol A. 1988 Nov;40(4):801-12
pubmed: 3212213
Schizophr Res. 2013 Nov;150(2-3):570-4
pubmed: 24075604
Behav Res Methods. 2008 Aug;40(3):879-91
pubmed: 18697684
Soc Psychiatry Psychiatr Epidemiol. 2020 May;55(5):645-657
pubmed: 31974809
Behav Res Ther. 2006 Apr;44(4):481-514
pubmed: 15913544
Brain. 2019 Feb 1;142(2):471-485
pubmed: 30535067
Nat Genet. 2016 Oct;48(10):1279-83
pubmed: 27548312
Biol Psychiatry. 2017 Mar 15;81(6):470-477
pubmed: 27765268
Cogn Neuropsychiatry. 2011 Sep;16(5):422-47
pubmed: 21480015
Arch Gen Psychiatry. 1991 Aug;48(8):764-70
pubmed: 1883262
Transl Psychiatry. 2018 Apr 12;8(1):78
pubmed: 29643358
Psychol Med. 2019 Jun;49(8):1378-1391
pubmed: 30282569
Nat Genet. 2016 Oct;48(10):1284-1287
pubmed: 27571263
Br J Clin Psychol. 2005 Jun;44(Pt 2):193-207
pubmed: 16004654
Cogn Neuropsychiatry. 2014;19(3):241-56
pubmed: 24215351
Nature. 2014 Jul 24;511(7510):421-7
pubmed: 25056061
J Pers Soc Psychol. 1986 Dec;51(6):1173-82
pubmed: 3806354
Cogn Neuropsychiatry. 2013;18(6):574-93
pubmed: 23167265
JAMA Psychiatry. 2018 Jan 1;75(1):36-46
pubmed: 29214289
Clin Psychol Rev. 2016 Jun;46:151-67
pubmed: 27216559
Schizophr Bull. 2015 Mar;41(2):411-8
pubmed: 25053654
J Neuropsychol. 2012 Mar;6(1):65-78
pubmed: 22257612
Arch Gen Psychiatry. 2009 Mar;66(3):236-47
pubmed: 19255373
Schizophr Res. 2008 Jul;102(1-3):254-60
pubmed: 18442898
Br J Clin Psychol. 2013 Nov;52(4):380-93
pubmed: 24117911
Schizophr Res. 2018 Jul;197:2-8
pubmed: 29129507
Cogn Neuropsychiatry. 2012;17(2):97-114
pubmed: 21722053
J Abnorm Psychol. 2010 Feb;119(1):40-9
pubmed: 20141241
Br J Psychiatry Suppl. 2007 Dec;51:s38-42
pubmed: 18055936
JAMA Psychiatry. 2014 Oct;71(10):1103-11
pubmed: 25103718
Br J Clin Psychol. 1999 Jun;38(2):113-54
pubmed: 10389596
Cogn Neuropsychiatry. 2006 Nov;11(6):521-36
pubmed: 17354086
Aust N Z J Psychiatry. 2012 Jun;46(6):532-40
pubmed: 22679205
Psychol Med. 2019 Aug;49(11):1799-1809
pubmed: 30160228
J Child Psychol Psychiatry. 2014 Oct;55(10):1068-87
pubmed: 25132410
Cogn Neuropsychiatry. 2007 Jan;12(1):46-77
pubmed: 17162446
PLoS One. 2014 Jul 25;9(7):e102683
pubmed: 25061949
Nature. 2009 Aug 6;460(7256):748-52
pubmed: 19571811
Nat Genet. 2018 Jul;50(7):912-919
pubmed: 29942086
Nat Genet. 2016 Nov;48(11):1443-1448
pubmed: 27694958
Schizophr Bull. 2016 May;42(3):652-65
pubmed: 26519952
Psychol Med. 2002 Feb;32(2):347-58
pubmed: 11866327
Lancet Psychiatry. 2019 May;6(5):427-436
pubmed: 30902669
Psychol Med. 2014 Oct;44(14):3017-24
pubmed: 25066636
Schizophr Bull. 2006 Apr;32(2):341-51
pubmed: 16254066
PLoS One. 2015 Jul 06;10(7):e0132442
pubmed: 26147948
Psychol Med. 2017 Jul;47(9):1573-1584
pubmed: 28166848
Schizophr Res. 2007 Aug;94(1-3):221-30
pubmed: 17524620
Br J Clin Psychol. 1997 May;36(2):243-58
pubmed: 9167864